|
| 37369443 | Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis. | Can J Surg | 2023 |
| 36136294 | Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study. | Clin Cancer Res | 2022 |
| 35400525 | Germline BRCA variants, lifestyle and ovarian cancer survival. | Gynecol Oncol | 2022 |
| 36210504 | Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. | J Natl Cancer Inst | 2022 |
| 36177562 | [Correlation analysis of clock genes and MEN2 medullary thyroid carcinoma]. | Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2022 |
| 32546565 | Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer. | J Med Genet | 2021 |
| 33593091 | A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy. | Cancer Control | 2021 |
| 34532101 | Lymph node metastasis risk factors and applicability of endoscopic submucosal dissection in mixed-type early gastric cancer in Chinese patients. | J Gastrointest Oncol | 2021 |
| 32473302 | Prognostic gene expression signature for high-grade serous ovarian cancer. | Ann Oncol | 2020 |
| 32107557 | Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D. | J Natl Cancer Inst | 2020 |
| 32555365 | Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium. | Br J Cancer | 2020 |
| 32283566 | DGUOK-AS1 promotes cell proliferation in cervical cancer via acting as a ceRNA of miR-653-5p. | Cell Biochem Funct | 2020 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |
| 30499236 | A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants. | Int J Cancer | 2019 |
| 31001917 | Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. | Cancer Med | 2019 |
| 29555990 | Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. | Br J Cancer | 2018 |
| 30134598 | rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. | Int J Mol Sci | 2018 |
| 30054336 | A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. | Cancer Res | 2018 |
| 29979793 | Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. | PLoS One | 2018 |
| 28063166 | Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. | Int J Cancer | 2017 |
| 28103614 | Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. | Br J Cancer | 2017 |
| 28346442 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. | Nat Genet | 2017 |
| 28881617 | Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility gene. | Oncotarget | 2017 |
| 28931370 | Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer. | BMC Cancer | 2017 |
| 27677730 | No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival. | Cancer Epidemiol Biomarkers Prev | 2017 |
| 25940428 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. | Gynecol Oncol | 2016 |
| 27644643 | Significant Efficacy of Additional Concurrent Chemotherapy with Radiotherapy for Postoperative Cervical Cancer with Risk Factors: a Systematic Review and Meta-analysis. | Asian Pac J Cancer Prev | 2016 |
| 27601076 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. | Nat Commun | 2016 |
| 27595995 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. | J Med Genet | 2016 |
| 27911851 | Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. | Oncotarget | 2016 |
| 27594614 | Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. | Int J Epidemiol | 2016 |
| 27533245 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. | Oncotarget | 2016 |
| 27349969 | Effects of estradiol on VEGF and bFGF by Akt in endometrial cancer cells are mediated through the NF-κB pathway. | Oncol Rep | 2016 |
| 27378695 | Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. | Hum Mol Genet | 2016 |
| 27401727 | Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. | Int J Epidemiol | 2016 |
| 27459707 | Telomere structure and maintenance gene variants and risk of five cancer types. | Int J Cancer | 2016 |
| 27432226 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. | Cancer Discov | 2016 |
| 26747452 | Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. | Cancer Epidemiol Biomarkers Prev | 2016 |
| 26711112 | Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. | Nat Genet | 2016 |
| 26851750 | The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. | Cancer Epidemiol | 2016 |
| 26823519 | PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. | J Natl Cancer Inst | 2016 |
| 26976855 | Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors. | Cancer Epidemiol Biomarkers Prev | 2016 |
| 27075448 | Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. | Hum Genet | 2016 |
| 25398451 | Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer. | Clin Cancer Res | 2015 |
| 26319099 | Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. | J Natl Cancer Inst | 2015 |
| 26586665 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. | J Natl Cancer Inst | 2015 |
| 26424751 | Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. | Carcinogenesis | 2015 |
| 26399219 | Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. | Genet Epidemiol | 2015 |
| 26315354 | Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. | J Natl Cancer Inst | 2015 |
| 26261251 | Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. | J Clin Oncol | 2015 |